Skip to main content
lexblog.com/lib/JWD32JCFviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "The FDA Releases Enhanced Regulatory Initiatives for Drug Compounders",
    "url": "http://www.skoutaris.eu/blog/2026/11/6/de-europeanising-border-conflicts-brexits-legal-toolkit",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-JWD32JCF",
        "url": "https://www.lexblog.com/lib/JWD32JCF/"
    },
    "datePublished": "2017-10-02T09:15:45-04:00",
    "dateModified": "2018-07-25T21:49:08-04:00",
    "author": {
        "@type": "Person",
        "name": "Rachael G. Pontikes, Emily L. Hussey, John D. Kendzior"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Reed Smith LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Life Sciences Legal Update",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.lifescienceslegalupdate.com/?p=5320",
    "sourceStability": "may-move"
}